Literature DB >> 27912158

Direct detection of phenylephrine 3-O-sulfate in LS180 human intestinal cells using a novel hydrophilic interaction liquid chromatography (HILIC) assay.

Heta N Shah1, Matthew T Halquist1, Phillip M Gerk2.   

Abstract

The efficacy of phenylephrine (PE) is controversial due to its extensive pre-systemic metabolism through sulfation to form phenylephrine-3-O-sulfate (PES). Hence quantitation of PES is important in order to study the metabolism of PE. There are no published methods available for direction detection of PES. We have developed and validated a hydrophilic interaction liquid chromatography (HILIC) method for the direct detection of PES and simultaneous detection of PE to study the enzyme kinetics and metabolism of PE to enable approaches to reduce the presystemic metabolism of PE. This is the first method which facilitates direct detection of PES and simultaneous detection of PE using a zwitterionic HILIC column with improved sensitivity in a single short run. The observed quantitative ranges of our method for PE and PES were 0.39-200μM and 0.0625-32μM (respectively) with a run time of 6.0min. The method was applied to the determination of PE and PES in LS180 human intestinal cell line, recombinant enzymes and human intestinal cytosol (HIC).
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug metabolism; HILIC; Phenylephrine; Sulfation; Sulfotransferase

Mesh:

Substances:

Year:  2016        PMID: 27912158     DOI: 10.1016/j.jchromb.2016.11.018

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

1.  Study to Probe Subsistence of Host-Guest Inclusion Complexes of α and β-Cyclodextrins with Biologically Potent Drugs for Safety Regulatory Dischargement.

Authors:  Biplab Rajbanshi; Subhadeep Saha; Koyeli Das; Biraj Kumar Barman; Swarnab Sengupta; Arindam Bhattacharjee; Mahendra Nath Roy
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.